The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
A Randomized, Double-Blind, Placebo-Controlled Trial of Citicoline for Cocaine Dependence in Bipolar I Disorder
Abstract
OBJECTIVE: Although drug dependence is common in patients with bipolar disorder, minimal data are available on the treatment of drug dependence in this patient population. The authors previously reported a decreased risk of relapse to cocaine use in a pilot study of citicoline in patients with bipolar disorder and cocaine dependence. The primary aim of the present study was to determine whether citicoline reduces cocaine use in outpatients with bipolar I disorder and current cocaine dependence and active cocaine use. METHOD: A total of 130 outpatients with bipolar I disorder (depressed or mixed mood state) and cocaine dependence received citicoline or placebo add-on therapy for 12 weeks. Results of thrice-weekly urine drug screens were analyzed using a generalized linear mixed model that was fitted to the binary outcome of cocaine-positive screens at each measurement occasion for 12 weeks. Mood was assessed with the Inventory of Depressive Symptomatology-Self Report, the Hamilton Depression Rating Scale, and the Young Mania Rating Scale. RESULTS: In the intent-to-treat sample (N=61 in both groups), significant treatment group and group-by-time effects were observed, whether or not missing urine screens were imputed as cocaine positive. The group effect was greatest early in the study and tended to decline with time. No between-group differences in mood symptoms or side effects were observed. CONCLUSIONS: Citicoline was well tolerated for treatment of cocaine dependence in patients with bipolar disorder. Cocaine use was significantly reduced with citicoline initially, although treatment effects diminished over time, suggesting the need for augmentation strategies to optimize long-term benefit.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Citicoline adjunctive therapy had a positive outcome in two RCTs in patients with BD with comorbid cocaine use disorder, although the benefits of citicoline decreased over time in the more recent study (level 2).705, 706”
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
McLELLAN, A. T., LUBORSKY, L., WOODY, G. E., & O??BRIEN, C. P. (1980) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198001000-00006 · Cited by 3,188
Merikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M. A., Petukhova, M., & Kessler, R. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.543 · Cited by 2,399
An Assessment of Clinically Useful Measures of the Consequences of Treatment
Laupacis, A., Sackett, D. L., & Roberts, R. S. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806303182605 · Cited by 1,681
Kessler, R. C., Nelson, C. B., McGonagle, K. A., Edlund, M. J., Frank, R. G., & Leaf, P. J. (1996) · American Journal of Orthopsychiatry · doi:10.1037/h0080151 · Cited by 1,378
TRIVEDI, M. H., RUSH, A. J., IBRAHIM, H. M., CARMODY, T. J., BIGGS, M. M., SUPPES, T., CRISMON, M. L., SHORES-WILSON, K., TOPRAC, M. G., DENNEHY, E. B., et al. (2004) · Psychological Medicine · doi:10.1017/s0033291703001107 · Cited by 968
Self-citationOutcome in Mania: A 4-Year Prospective Follow-up of 75 Patients Utilizing Survival Analysis
Tohen, M. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810240026005 · Cited by 532
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.6.856 · Cited by 486
The development of a cocaine craving questionnaire
Tiffany, S. T., Singleton, E., Haertzen, C. A., & Henningfield, J. E. (1993) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(93)90042-o · Cited by 435
Outcome of Bipolar Disorder on Long-Term Treatment with Lithium
O'Connell, R. A., Mayo, J. A., Flatow, L., Cuthbertson, B., & O'Brien, B. E. (1991) · British Journal of Psychiatry · doi:10.1192/bjp.159.1.123 · Cited by 333
Reporting Number Needed to Treat and Absolute Risk Reduction in Randomized Controlled Trials
Nuovo, J. (2002) · JAMA · doi:10.1001/jama.287.21.2813 · Cited by 241
Citicoline: pharmacological and clinical review, 2010 update.
Secades, J. J. (2011) · PubMed · Cited by 216
Bauer, M. S., Altshuler, L., Evans, D. R., Beresford, T., Williford, W. O., & Hauger, R. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.11.009 · Cited by 213
Substance Abuse and Bipolar Affective Disorder
SONNE, S. C., BRADY, K. T., & MORTON, W. A. (1994) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199406000-00007 · Cited by 211
Higgins, S. T., Alessi, S. M., & Dantona, R. L. (2002) · Addictive Behaviors · doi:10.1016/s0306-4603(02)00297-6 · Cited by 201
Thase, M. E. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830090023004 · Cited by 200
Factors associated with treatment nonadherence among US bipolar disorder patients
Baldessarini, R. J., Perry, R., & Pike, J. (2008) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.908 · Cited by 198
Fioravanti, M., & Yanagi, M. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000269.pub3 · Cited by 184
The Role of Acetylcholine in Cocaine Addiction
Williams, M. J., & Adinoff, B. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301585 · Cited by 173
Self-citationSources of lithium resistance in mixed mania.
Himmelhoch, J. M., & Garfinkel, M. E. (1986) · PubMed · Cited by 165
Substance misuse and risk of aggression and offending among the severely mentally ill
Scott, H., Johnson, S., Menezes, P., Bindman, J., Thornicroft, G., Marshall, J., Bebbington, P., & Kuipers, E. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.172.4.345 · Cited by 159
Dixon, C. E., Ma, X., & Marion, D. W. (1997) · Journal of Neurotrauma · doi:10.1089/neu.1997.14.161 · Cited by 149
Sajatovic, M., Ignacio, R. V., West, J. A., Cassidy, K. A., Safavi, R., Kilbourne, A. M., & Blow, F. C. (2008) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2008.06.008 · Cited by 139
Drug abuse and bipolar disorder: comorbidity or misdiagnosis?
Brown, E. S., Suppes, T. M., Adinoff, B. H., & Thomas, N. R. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00169-5 · Cited by 133
Self-citationPerlis, R. H., Ostacher, M. J., Miklowitz, D. J., Hay, A. C., Nierenberg, A. A., Thase, M. E., & Sachs, G. S. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05514yel · Cited by 116
Cho, H.-J., & Kim, Y. (2009) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2009.31.3.1364241 · Cited by 93
Brown, E. S., Gorman, A. R., & Hynan, L. S. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31814db4c4 · Cited by 79
Self-citationSchmitz, J. M., Averill, P. M., Sayre, S. L., McCleary, P., Moeller, F. G., & Swann, A. C. (2002) · Addictive Disorders & Their Treatment · doi:10.1097/00132576-200205000-00004 · Cited by 75
Self-citationOxcarbazepine Treatment of Bipolar Disorder
Ghaemi, S. N., Berv, D. A., Klugman, J., Rosenquist, K. J., & Hsu, D. J. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0813 · Cited by 70
Brown, E. S., & Gabrielson, B. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.05.006 · Cited by 58
Self-citationSilveri, M. M., Dikan, J., Ross, A. J., Jensen, J. E., Kamiya, T., Kawada, Y., Renshaw, P. F., & Yurgelun-Todd, D. A. (2008) · NMR in Biomedicine · doi:10.1002/nbm.1281 · Cited by 55
Carbamazepine in the treatment of cocaine dependence: Subtyping by affective disorder.
Brady, K. T., Sonne, S. C., Malcolm, R. J., Randall, C. L., Simpson, K., Dansky, B. S., Roberts, J. S., & Brondino, M. J. (2002) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.10.3.276 · Cited by 54
Petkov, V. D., Stancheva, S. L., Tocuschieva, L., & Petkov, V. V. (1990) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(90)90598-g · Cited by 47
Brown, E. S., Sunderajan, P., Hu, L. T., Sowell, S. M., & Carmody, T. J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.90 · Cited by 46
Self-citationRenshaw, P. F., Daniels, S., Lundahl, L. H., Rogers, V., & Lukas, S. E. (1999) · Psychopharmacology · doi:10.1007/s002130050871 · Cited by 46
Citicoline in addictive disorders: a review of the literature
Wignall, N. D., & Brown, E. S. (2014) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2014.925467 · Cited by 34
Self-citationALKAN, T., Kahveci, N., Gören, B., Korfalı, E., & Ozluk, K. (2001) · Archives of Physiology and Biochemistry · doi:10.1076/apab.109.2.161.4273 · Cited by 24
Licata, S. C., Penetar, D. M., Ravichandran, C. T., Rodolico, J. M., Palmer, C., Berko, J., Geaghan, T. R., Looby, A. R., Peters, E. N., Ryan, E. T., et al. (2010) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e3181d80c93 · Cited by 21
Saxon, A. J., Calsyn, D. A., Stanton, V. V., & Hawker, C. S. (1994) · American Journal on Addictions · doi:10.3109/10550499409117265 · Cited by 14
A Pilot Study of Quetiapine in Patients With Bipolar Disorder and Cocaine Dependence
Brown, E. S., Gabrielson, B., & Gu, P. (2010) · Journal of Dual Diagnosis · doi:10.1080/15504260903405347 · Cited by 8
Self-citation
Research works printed but not linked: 4
- Himmelhoch JM, 1986, Psychopharmacol Bull, 22, 613
- Fioravanti M, 2005, Cochrane Database Syst Rev, 2, CD000269
- Secades JJ, 2006, Methods Find Exp Clin Pharmacol, 28, 1
- First MB, 1995, Structured Clinical Interview for DSM-IV Axis I Disorders (SCID), Clinician Version
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Bentzley, B. S., Han, S. S., Neuner, S., Humphreys, K., Kampman, K. M., & Halpern, C. H. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.8049 · Cited by 161
Fountoulakis, K. Ν., Yatham, L. N., Grunze, H., Vieta, E., Young, A. H., Blier, P., Kasper, S. F., & Moeller, H. J. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw100 · Cited by 126
Management of comorbid bipolar disorder and substance use disorders
Salloum, I. M., & Brown, E. S. (2017) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2017.1292279 · Cited by 104
Self-citationTreatment of substance use disorders with co-occurring severe mental health disorders
Murthy, P., Mahadevan, J., & Chand, P. (2019) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000510 · Cited by 83
Metadata
- Authors
- Brown, E. S., Todd, J. P., Hu, L. T., Schmitz, J. M., Carmody, T. J., Nakamura, A., Sunderajan, P., Rush, A. J., Adinoff, B., Bret, M. E., Holmes, T., & Lo, A.
- Affiliations
- National University of Singapore (SG)
- Venue
- American Journal of Psychiatry
- Published
- 2015-10-01
- Volume
- 172
- Issue
- 10
- Pages
- 1014-1021
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2157470749
- Cited by
- 36
- References
- 43
- Citations by year
- 2024: 6 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 2 · 2018: 7 · 2017: 7 · 2016: 3 · 2015: 1
- FWCI
- 4.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (R01DA022460, DA022460)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- citicoline, cocaine dependence, bipolar I disorder, cocaine use reduction, relapse prevention, mood symptoms, treatment tolerance
- MeSH terms
- Adult, Bipolar Disorder, Cytidine Diphosphate Choline, Double-Blind Method, Female, Humans, Male, Middle Aged, Treatment Outcome, Antimanic Agents, Nootropic Agents, Cocaine-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.